Chemical Structure (Avapro 01)
Avapro Tablet, Film Coated
Product Images NDC 0024-5852
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Avapro (NDC 0024-5852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Avapro 02)
Figure 2 (Avapro 03)
Figure 3 (Avapro 04)
This is a graphical representation of the cumulative event rate (%) in a clinical trial comparing the effects of AVAPRO and Amlodipine with Placebo as a control group over a period of 54-60 months of follow-up. The data shows that AVAPRO has a significant impact on reducing the event rate compared to both Amlodipine and Placebo. There are no further details available apart from the chart.*
Principal Display Panel (75 mg Tablet Bottle Label)
Principal Display Panel (150 mg Tablet Bottle Label)
Principal Display Panel (300 mg Tablet Bottle Label)
Avapro Tablets, with NDC 0024-5852-30, contains 300mg of irbesartan per tablet. The medication is available in a bottle of 30 tablets and is prescribed only. The recommended dosing information can be found in the package insert. It is recommended to store these tablets at a controlled room temperature between 15°C and 30°C (59°F-86°F).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
